Acute decompensated heart failure in children is characterized by high burdens of comorbidities, mortality, and frequent readmission, especially among patients with underlying congenital heart disease.
Large adult body size contributes to the association between genetically predicted larger body size in childhood and coronary artery disease and type 2 diabetes later in life.
From 2007 to 2016, pediatric emergency department visits remained stable, but visits for all mental health disorders increased 60 percent.
Researchers found strong evidence that polygenic scores for adult major depression, subjective wellbeing, neuroticism, insomnia, educational attainment, and BMI are associated with childhood ADHD symptoms, internalizing and social problems.
Just one in five pediatric cancer patients enroll in clinical trials, down from 40 to 70 percent during the 1990s and 20 to 25 percent in the early 2000s.
The presence of obesity, T2D, and elevated systolic blood pressure in adolescence accelerates the progression of risk factors that play a role in the development of early vascular aging.
New polices, including testing for hepatitis C virus (HCV) during pregnancy, may increase HCV identification in the pediatric population by addressing gaps in maternal HCV testing.
The Food and Drug Administration (FDA) has expanded the approval of Cymbalta (duloxetine; Lilly) to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.
For men, early age at puberty is associated with an increased risk for type 2 diabetes.
The use of prenatal vitamin D supplementation alone has no effect on the 6-year incidence of asthma and recurrent wheeze in children considered to be at risk.
